Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Radiotherapy underutilisation and its impact on local control and survival in New South Wales, Australia.

Merie R, Gabriel G, Shafiq J, Vinod S, Barton M, Delaney GP.

Radiother Oncol. 2019 Dec;141:41-47. doi: 10.1016/j.radonc.2019.09.012. Epub 2019 Oct 9.

PMID:
31606225
2.

Rifampicin conjugated silver nanoparticles: a new arena for development of antibiofilm potential against methicillin resistant Staphylococcus aureus and Klebsiella pneumoniae.

Farooq U, Ahmad T, Khan A, Sarwar R, Shafiq J, Raza Y, Ahmed A, Ullah S, Ur Rehman N, Al-Harrasi A.

Int J Nanomedicine. 2019 May 29;14:3983-3993. doi: 10.2147/IJN.S198194. eCollection 2019.

3.

Estimating the cost of radiotherapy for 5-year local control and overall survival benefit.

Batumalai V, Wong K, Shafiq J, Hanna TP, Gabriel G, Heberle J, Koprivic I, Kaadan N, King O, Tran T, Cassapi L, Forstner D, Delaney GP, Barton M.

Radiother Oncol. 2019 Jul;136:154-160. doi: 10.1016/j.radonc.2019.04.011. Epub 2019 Apr 20.

PMID:
31015119
4.

Patterns of follow-up care after curative radiotherapy ± chemotherapy for stage I-III non-small cell lung cancer.

Mohan S, Beydoun N, Nasser E, Nguyen A, Shafiq J, Vinod S.

Asia Pac J Clin Oncol. 2019 Jun;15(3):172-180. doi: 10.1111/ajco.13127. Epub 2019 Feb 13.

PMID:
30761737
5.

Radiotherapy patterns of care for stage I and II non-small cell lung cancer in Sydney, Australia.

Nguyen AD, Wong W, Beydoun N, Mohan S, Shafiq J, Vinod SK.

J Med Imaging Radiat Oncol. 2019 Feb;63(1):131-141. doi: 10.1111/1754-9485.12819. Epub 2018 Oct 3.

PMID:
30281917
6.

Impact of radiotherapy underutilisation measured by survival shortfall, years of potential life lost and disability-adjusted life years lost in New South Wales, Australia.

Batumalai V, Shafiq J, Gabriel G, Hanna TP, Delaney GP, Barton M.

Radiother Oncol. 2018 Nov;129(2):191-195. doi: 10.1016/j.radonc.2018.06.026. Epub 2018 Jul 5.

PMID:
29983259
7.

The population benefit of evidence-based radiotherapy: 5-Year local control and overall survival benefits.

Hanna TP, Shafiq J, Delaney GP, Vinod SK, Thompson SR, Barton MB.

Radiother Oncol. 2018 Feb;126(2):191-197. doi: 10.1016/j.radonc.2017.11.004. Epub 2017 Dec 8.

8.

The Benefits of Providing External Beam Radiotherapy in Low- and Middle-income Countries.

Yap ML, Hanna TP, Shafiq J, Ferlay J, Bray F, Delaney GP, Barton M.

Clin Oncol (R Coll Radiol). 2017 Feb;29(2):72-83. doi: 10.1016/j.clon.2016.11.003. Epub 2016 Dec 1.

PMID:
27916340
9.

Comparison of Magnetic Resonance Imaging and Computed Tomography for Breast Target Volume Delineation in Prone and Supine Positions.

Pogson EM, Delaney GP, Ahern V, Boxer MM, Chan C, David S, Dimigen M, Harvey JA, Koh ES, Lim K, Papadatos G, Yap ML, Batumalai V, Lazarus E, Dundas K, Shafiq J, Liney G, Moran C, Metcalfe P, Holloway L.

Int J Radiat Oncol Biol Phys. 2016 Nov 15;96(4):905-912. doi: 10.1016/j.ijrobp.2016.08.002. Epub 2016 Aug 11.

PMID:
27788960
10.

A Population-based Model of Local Control and Survival Benefit of Radiotherapy for Lung Cancer.

Shafiq J, Hanna TP, Vinod SK, Delaney GP, Barton MB.

Clin Oncol (R Coll Radiol). 2016 Oct;28(10):627-38. doi: 10.1016/j.clon.2016.05.006. Epub 2016 May 31. Review.

PMID:
27260488
11.

Estimation of the optimal utilisation rates of radical prostatectomy, external beam radiotherapy and brachytherapy in the treatment of prostate cancer by a review of clinical practice guidelines.

Thompson SR, Delaney GP, Jacob S, Shafiq J, Wong K, Hanna TP, Gabriel GS, Barton MB.

Radiother Oncol. 2016 Jan;118(1):118-21. doi: 10.1016/j.radonc.2015.12.023. Epub 2016 Jan 8.

PMID:
26776443
12.

The population benefit of radiotherapy for cervical cancer: local control and survival estimates for optimally utilized radiotherapy and chemoradiation.

Hanna TP, Shafiq J, Delaney GP, Barton MB.

Radiother Oncol. 2015 Mar;114(3):389-94. doi: 10.1016/j.radonc.2015.02.005. Epub 2015 Feb 27.

PMID:
25733007
13.

Estimating the population benefit of radiotherapy: using demand models to estimate achievable cancer outcomes.

Hanna TP, Shafiq J.

Clin Oncol (R Coll Radiol). 2015 Feb;27(2):99-106. doi: 10.1016/j.clon.2014.10.011. Epub 2014 Nov 25. Review.

PMID:
25466333
14.

Estimating the demand for radiotherapy from the evidence: a review of changes from 2003 to 2012.

Barton MB, Jacob S, Shafiq J, Wong K, Thompson SR, Hanna TP, Delaney GP.

Radiother Oncol. 2014 Jul;112(1):140-4. doi: 10.1016/j.radonc.2014.03.024. Epub 2014 May 12. Review.

PMID:
24833561
15.

A comparison of surgical and radiotherapy breast cancer therapy utilization in Canada (British Columbia), Scotland (Dundee), and Australia (Western Australia) with models of "optimal" therapy.

Fong A, Shafiq J, Saunders C, Thompson AM, Tyldesley S, Olivotto IA, Barton MB, Dewar JA, Jacob S, Ng W, Speers C, Delaney GP.

Breast. 2012 Aug;21(4):570-7. doi: 10.1016/j.breast.2012.02.014. Epub 2012 Mar 16.

16.

A comparison of systemic breast cancer therapy utilization in Canada (British Columbia), Scotland (Dundee), and Australia (Western Australia) with models of "optimal" therapy.

Fong A, Shafiq J, Saunders C, Thompson A, Tyldesley S, Olivotto IA, Barton MB, Dewar JA, Jacob S, Ng W, Speers C, Delaney GP.

Breast. 2012 Aug;21(4):562-9. doi: 10.1016/j.breast.2012.01.006. Epub 2012 Jan 31.

17.

Do multidisciplinary team meetings make a difference in the management of lung cancer?

Boxer MM, Vinod SK, Shafiq J, Duggan KJ.

Cancer. 2011 Nov 15;117(22):5112-20. doi: 10.1002/cncr.26149. Epub 2011 Apr 26.

18.

Management of skin toxicity during radiation therapy: a review of the evidence.

Kumar S, Juresic E, Barton M, Shafiq J.

J Med Imaging Radiat Oncol. 2010 Jun;54(3):264-79. doi: 10.1111/j.1754-9485.2010.02170.x. Review.

PMID:
20598015
19.

Dosimetric implications of the addition of 18 fluorodeoxyglucose-positron emission tomography in CT-based radiotherapy planning for non-small-cell lung cancer.

Vinod SK, Kumar S, Holloway LC, Shafiq J.

J Med Imaging Radiat Oncol. 2010 Apr;54(2):152-60. doi: 10.1111/j.1754-9485.2010.02155.x.

PMID:
20518880
20.

Patients' and health care professionals' evaluation of health-related quality of life issues in bone metastases.

Harris K, Chow E, Zhang L, Velikova G, Bezjak A, Wu J, Barton M, Sezer O, Eek R, Shafiq J, Yee A, Clemons M, Brundage M, Hoskin P, van der Linden Y, Johnson CD, Bottomley A; EORTC Quality of Life Group.

Eur J Cancer. 2009 Sep;45(14):2510-8. doi: 10.1016/j.ejca.2009.05.024. Epub 2009 Jul 25.

PMID:
19635661
21.

Use of chemotherapy at end of life in oncology patients.

Kao S, Shafiq J, Vardy J, Adams D.

Ann Oncol. 2009 Sep;20(9):1555-9. doi: 10.1093/annonc/mdp027. Epub 2009 May 25.

PMID:
19468033
22.

An international review of patient safety measures in radiotherapy practice.

Shafiq J, Barton M, Noble D, Lemer C, Donaldson LJ.

Radiother Oncol. 2009 Jul;92(1):15-21. doi: 10.1016/j.radonc.2009.03.007. Epub 2009 Apr 22. Erratum in: Radiother Oncol. 2009 Dec;93(3):657.

PMID:
19395105
23.

The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for patients with bone metastases: the EORTC QLQ-BM22.

Chow E, Hird A, Velikova G, Johnson C, Dewolf L, Bezjak A, Wu J, Shafiq J, Sezer O, Kardamakis D, van der Linden Y, Ma B, Castro M, Arnalot PF, Ahmedzai S, Clemons M, Hoskin P, Yee A, Brundage M, Bottomley A; EORTC Quality of Life Group.

Eur J Cancer. 2009 May;45(7):1146-1152. doi: 10.1016/j.ejca.2008.11.013. Epub 2008 Dec 25.

PMID:
19097882
24.

Establishing treatment benchmarks for mammography-screened breast cancer population based on a review of evidence-based clinical guidelines.

Delaney G, Shafiq J, Chappell G, Barton M.

Cancer. 2008 May 1;112(9):1912-22. doi: 10.1002/cncr.23384.

25.

An evidence-based estimation of local control and survival benefit of radiotherapy for breast cancer.

Shafiq J, Delaney G, Barton MB.

Radiother Oncol. 2007 Jul;84(1):11-7. Epub 2007 Mar 30.

PMID:
17399830
26.

Role of radiotherapy in cancer control in low-income and middle-income countries.

Barton MB, Frommer M, Shafiq J.

Lancet Oncol. 2006 Jul;7(7):584-95. Erratum in: Lancet Oncol. 2006 Oct;7(10):797.

PMID:
16814210
27.

Polyclonal expansion of peripheral gamma delta T cells in human Plasmodium falciparum malaria.

Ho M, Tongtawe P, Kriangkum J, Wimonwattrawatee T, Pattanapanyasat K, Bryant L, Shafiq J, Suntharsamai P, Looareesuwan S, Webster HK, Elliott JF.

Infect Immun. 1994 Mar;62(3):855-62.

29.

Cardiopulmonary bypass and plasma taurine.

Irita K, Yoshitake S, Okabe H, Shafiq J, Mohammad TF, Yoshitake J, Takahashi S.

J Anesth. 1993 Jul;7(3):352-6. No abstract available.

PMID:
15278823
30.
31.
32.

Membrane hyperpolarization inhibits agonist-induced synthesis of inositol 1,4,5-trisphosphate in rabbit mesenteric artery.

Suzuki S, Ito S, Suzuki A, Shafiq J, Seki N, Kajikuri J, Itoh T, Kuriyama H.

Jpn J Pharmacol. 1992;58 Suppl 2:344P. No abstract available.

33.

Factors affecting hypomagnesemia after cardiopulmonary bypass.

Irita K, Shafiq J, Yoshitake S, Tareen FM, Yoshitake J.

Can J Anaesth. 1990 May;37(4 Pt 2):S120. No abstract available.

PMID:
2361257

Supplemental Content

Loading ...
Support Center